219
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma

, , , , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 91-98 | Received 16 Sep 2022, Accepted 10 Jan 2023, Published online: 22 Jan 2023

References

  • Altekruse SF, Henley SJ, Cucinelli JE, et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2018;109(4):542–553. doi:10.1038/ajg.2014.11
  • Balogh J, Victor D, Asham EH, et al. Hepatocellular carcinoma: a review. J Hepatocell Carcinoma. 2016;3:41–53. doi:10.2147/JHC.S61146
  • Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–1092. doi:10.1002/lt.20472
  • Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat Rec. 2008;291:721–734. doi:10.1002/ar.20668
  • Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254:108–113. doi:10.1097/SLA.0b013e31821ad884
  • Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int. 2009;29(4):502–510. doi:10.1111/j.1478-3231.2008.01957.x
  • Colecchia A, Schiumerini R, Cucchetti A, et al. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol. 2014;20(20):5935–5950. doi:10.3748/wjg.v20.i20.5935
  • Dudek K, Kornasiewicz O, Remiszewski P, et al. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma. Transplant Proc. 2009;41(8):3135–3137. doi:10.1016/j.transproceed.2009.08.016
  • Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850–855. doi:10.1053/j.gastro.2009.06.003
  • Selcuk H. Prognostic factors and staging systems in hepatocellular carcinoma. Exp Clin Transplant. 2017;15(Suppl 2):45–49. doi:10.6002/ect.TOND16.L11
  • Shah SA, Tan JC, McGilvray ID, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellularcarcinoma. Transplantation. 2006;81:1633–1639. doi:10.1097/01.tp.0000226069.66819.7e
  • Amin MB. AJCC Cancer Staging Manual. 8 ed. Springer; 2017.
  • Rodríguez-Perálvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20:325–339. doi:10.1245/s10434-012-2513-1
  • Fan L, Mac MT, Frishberg DP, et al. Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma. J Gastroenterol Hepatol. 2010;25:1556–1561. doi:10.1111/j.1440-1746.2010.06304.x
  • Fujita N, Aishima S, Iguchi T, et al. Histologic classification of microscopic portal venous invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850–855.
  • Schlageter M, Terracciano LM, D’angelo S, et al. Histopathology of hepatocellular carcinoma. World J Gastroenterol. 2014;20(43):15955–15964. doi:10.3748/wjg.v20.i43.15955
  • Harris EI, Lewin DN, Wang HL, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol. 2008;32:1816–1821. doi:10.1097/PAS.0b013e3181816083
  • Salizzoni M, Romagnoli R, Lupo F, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2003;76(5):844–848. doi:10.1097/01.TP.0000083555.06337.8E
  • Franc B, De La Salmonière P, Hoang C, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol. 2003;34(11):1092–1100. doi:10.1016/S0046-8177(03)00403-9
  • Rakha EA, Abbas A, Ellis IO, et al. Diagnostic concordance of reporting lymphovascular invasion in breast cancer. J Clin Pathol. 2018;71(9):802–805. doi:10.1136/jclinpath-2017-204981
  • Huber AR, Gonzalez RS, Orloff MS, Barry CT, Whitney-Miller CL. Accuracy of vascular invasion reporting in hepatocellular carcinoma before and after implementation of subspecialty surgical pathology sign-out. Indian J Pathol Microbiol. 2017;60:501–504. doi:10.4103/IJPM.IJPM_827_16
  • Krishnan MS, Rajan KD. Genomic analysis of vascular invasion in HCC reveals molecular drivers and predictive biomarkers. Hepatology. 2021;73:2342–2360. doi:10.1002/hep.31614